Grading urothelial carcinoma with probe-based confocal laser endomicroscopy during flexible cystoscopy - Takeaways - MDSpire

Grading urothelial carcinoma with probe-based confocal laser endomicroscopy during flexible cystoscopy

  • By

  • Ben-Max de Ruiter

  • Jan Erik Freund

  • C. Dilara Savci-Heijnink

  • Jons W. van Hattum

  • Theo M. de Reijke

  • Joyce Baard

  • Guido M. Kamphuis

  • D. Martijn de Bruin

  • Jorg R. Oddens

  • July 27, 2024

  • 0 min

Share

  • 1

    Bladder cancer is the 10th most common cancer globally, with urothelial carcinoma accounting for over 90% of cases in high-income countries.

  • 2

    Non-muscle invasive bladder cancer has high recurrence rates, leading to significant patient burden and healthcare costs due to frequent cystoscopic follow-ups.

  • 3

    Probe-based confocal laser endomicroscopy (CLE) offers real-time assessment of suspicious bladder lesions during flexible cystoscopy.

  • 4

    The CystoflexF probe is compatible with flexible cystoscopes and has similar imaging properties to the UroflexF probe, which has shown diagnostic promise.

  • 5

    The CLETUR trial aims to evaluate the diagnostic accuracy of CLE during flexible cystoscopy and compare it with the CystoflexUHD-R probe.

Original Source(s)

Grading urothelial carcinoma with probe-based confocal laser endomicroscopy during flexible cystoscopy

  • by Ben-Max de Ruiter, Jan Erik Freund, C. Dilara Savci-Heijnink, Jons W. van Hattum, Theo M. de Reijke, Joyce Baard, Guido M. Kamphuis, D. Martijn de Bruin, Jorg R. Oddens

  • July 27, 2024

Related Content

Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma

Targeted transperineal biopsy of the prostate has limited additional benefit over background cores for larger MRI-identified tumors

Predicting invasiveness and disease-specific survival in upper tract urothelial carcinoma: identifying relevant clinical tumour characteristics